$SVRA
$SVRA
Savara
Savara is a clinical-stage biopharmaceutical company developing therapies for rare respiratory diseases, including a treatment for autoimmune pulmonary alveolar proteinosis.
Stocks
$136
1
$137.13
Savara Metrics
Metric
Show % of Total
Tokenized Public Stocks
10 TotalRWA.xyzAll Rights Reserved